Literature DB >> 20309822

Benefits of kinesiotherapy and aquatic rehabilitation on sickle cell anemia. A case report.

G Tinti1, R Somera, F M Valente, C R B Domingos.   

Abstract

The process of hemoglobin polymerization and the consequent sickling of red blood cells that occurs in patients with sickle cell disease shortens the half-life of red blood cells. It causes vaso-occlusive complications, as well as pain and pulmonary and cardiovascular dysfunction. We evaluated an aquatic rehabilitation program used for patients with sickle cell anemia and examined the possible benefits that exercise in warm water has for the circulatory system, for relieving pain, and for increasing lung capacity. The patient was a 32-year-old female. The parameters that we used in this study include respiratory muscle strength (which was calculated by measuring maximum inspiratory pressures and maximum expiratory pressures), the McGill and Wisconsin pain questionnaires (in order to evaluate the patients' characterizations and descriptions of their pain), and the SF-36 Health Survey. The treatment included warm water exercises, stretching, aerobic exercise, and relaxation, during two sessions of 45 min per week for 5 weeks. The patient experienced a significant decrease in pain, a significant increase in the strength of respiratory muscles, and improved quality of life. We conclude that aquatic rehabilitation can be used to improve the clinical condition of sickle cell anemia patients, and we encourage more research on this new treatment regime, in comparison with other types of therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20309822     DOI: 10.4238/vol9-1gmr722

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  8 in total

1.  Exercise Testing of Adolescents and Young Adults With Sickle Cell Disease: Perceptual Responses and the Gas Exchange Threshold.

Authors:  Suzanne Ameringer; R K Elswick; India Sisler; Wally Smith; Thokozeni Lipato; Edmund O Acevedo
Journal:  J Pediatr Oncol Nurs       Date:  2019-04-26       Impact factor: 1.636

Review 2.  Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain.

Authors:  Hants Williams; Paula Tanabe
Journal:  J Pain Symptom Manage       Date:  2015-11-17       Impact factor: 3.612

3.  Updated Mechanisms of Sickle Cell Disease-Associated Chronic pain.

Authors:  Brianna Lutz; Steffen E Meiler; Alex Bekker; Yuan-Xiang Tao
Journal:  Transl Perioper Pain Med       Date:  2015-07-26

Review 4.  Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.

Authors:  Erica N Chirico; Camille Faës; Philippe Connes; Emmanuelle Canet-Soulas; Cyril Martin; Vincent Pialoux
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

5.  Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research.

Authors:  Marsha J Treadwell; Kathryn Hassell; Roger Levine; San Keller
Journal:  Clin J Pain       Date:  2014-10       Impact factor: 3.442

6.  The Role of Inspiratory Muscle Training in Sickle Cell Anemia Related Pulmonary Damage due to Recurrent Acute Chest Syndrome Attacks.

Authors:  Burcu Camcıoğlu; Meral Boşnak-Güçlü; Müşerrefe Nur Karadallı; Şahika Zeynep Akı; Gülsan Türköz-Sucak
Journal:  Case Rep Hematol       Date:  2015-04-28

7.  Impact of A Six Week Training Program on Ventilatory Efficiency, Red Blood Cell Rheological Parameters and Red Blood Cell Nitric Oxide Signaling in Young Sickle Cell Anemia Patients: A Pilot Study.

Authors:  Marijke Grau; Elie Nader; Max Jerke; Alexander Schenk; Celine Renoux; Thomas Dietz; Bianca Collins; Daniel Alexander Bizjak; Philippe Joly; Wilhelm Bloch; Aram Prokop; Philippe Connes
Journal:  J Clin Med       Date:  2019-12-05       Impact factor: 4.241

8.  Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.

Authors:  Francesca Rodigari; Giorgia Brugnera; Raffaella Colombatti
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.